Comments
Panacea Biotec on Monday inked a tripartite pact with Natco Pharma and Breckenridge Pharmaceutical Inc to manufacture and supply Azacitidine injection, a chemotherapy drug, for the US market. Under its terms, Natco has provided the technology for manufacturing Azacitidine to Panacea Biotec’s Baddi facility. Panacea will manufacture and supply the product, which will be marketed and distributed by Breckenridge in the US.
Comments
Comments
Comments have to be in English, and in full sentences. They cannot be abusive or personal. Please abide by our community guidelines for posting your comments.
We have migrated to a new commenting platform. If you are already a registered user of TheHindu Businessline and logged in, you may continue to engage with our articles. If you do not have an account please register and login to post comments. Users can access their older comments by logging into their accounts on Vuukle.